Wave II clinical study will evaluate THRV-1268, Thryv's oral SGK1 inhibitor, in adults with Long QT Syndrome Type 2. Wave II is informed by the successful Wave I clinical study with LQT-1213 and ...
Tippie business analytics professor Patrick Fan isn’t a physician, but his research and collaboration with health care faculty could improve cancer care. Fan is using AI and data from thousands of ...
LUXEMBOURG and BIRMINGHAM, England, Dec. 4, 2025 /PRNewswire/ -- LuxAI, together with the Luxembourg Institute of Health (LIH) and the University of Birmingham (UK), has launched the world's first ...
Black Friday is one week from today, launching another holiday shopping season, but a University of Iowa study finds people who are lonely may find themselves unable to resist the impulse to buy.
ABERDEEN — An observation a crop scientist made while glancing at a flower bed at the University of Idaho’s Aberdeen Research and Extension Center inspired a trial that could help Idaho mustard ...
Introduction: Ventricular arrhythmias and sudden cardiac death are among the leading causes of mortality in patients with chronic kidney disease (CKD). This risk arises from shared etiologies between ...
As a psychiatrist and therapist, I often hear the question: “Can AI replace a therapist?” A recent research study delivers a compelling answer: Not yet. Perhaps never entirely. The research explores ...
An ongoing University of Idaho Extension trial shows early promise for east-central Idaho farmers and ranchers hoping to raise two forage crops from a single field within the region’s short growing ...
NEWTON, Mass.--(BUSINESS WIRE)--Axena Health, Inc., a medical device company focused on female pelvic health, announced today it will present a late-breaking abstract at the International Federation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results